Evidence map›Paper›PMID 37114212›Full record

ArticleAmerican journal of preventive cardiology2023

The role of aldosterone and ideal cardiovascular health in incident cardiovascular disease: The Jackson heart study.

Bjorn Kluwe, Neal Pohlman, Veena Kesireddy, Songzhu Zhao, Yubo Tan, David Kline, Guy Brock, James B Odei, Valery S Effoe, Justin B Echouffo Tcheugui and 6 more

Open access · goldAbstract read
In one paragraph

Article in American journal of preventive cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 1 country.

Bjorn KluweDivision of Endocrinology, Diabetes and Metabolism, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States.
Neal PohlmanDivision of Endocrinology, Diabetes and Metabolism, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States.
Veena KesireddyDivision of Endocrinology, University Of Texas Medical Branch at Galveston, Galveston, Texas, United States.
Songzhu ZhaoCenter for Biostatistics, Department of Biomedical Informatics, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States.
Yubo TanCenter for Biostatistics, Department of Biomedical Informatics, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States.
David KlineDivision of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States.
Guy BrockCenter for Biostatistics, Department of Biomedical Informatics, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States.
James B OdeiDivision of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States.
Valery S EffoeDivision of Biostatistics, The Ohio State University College of Public Health, Columbus, Ohio, United States.
Justin B Echouffo TcheuguiDivision of Cardiology, Morehouse School of Medicine, Atlanta, Georgia, United States.
Rita R KalyaniDivision of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
Mario SimsDepartment of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, United States.
Herman A TaylorDivision of Cardiology, Morehouse School of Medicine, Atlanta, Georgia, United States.
Morgana Mongraw-ChaffinDepartment of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States.
Ehimare AkhabueDivision of Cardiovascular Diseases and Hypertension, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States.
Joshua J JosephDivision of Endocrinology, Diabetes and Metabolism, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States.
The Ohio State University Wexner Medical Center · USWake Forest University · USMorehouse School of Medicine · USJohns Hopkins University · USRutgers, The State University of New Jersey · USThe Ohio State University · USThe University of Texas Medical Branch at Galveston · USUniversity of Mississippi Medical Center · US

Funding

The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve HealthUL1TR002733 · NCATS · OHIO STATE UNIVERSITY · PI RINGEL, MATTHEW D · 2018 to 2022
$28.9M
The Role of The Renin-Angiotensin-Aldosterone System, ARMC5, and Neprilysin in Glucose Metabolism among African AmericansK23DK117041 · NIDDK · OHIO STATE UNIVERSITY · PI JOSEPH, JOSHUA J · 2018 to 2022
$1.0M
NCATS NIH HHS UL1 TR002733NHLBI NIH HHS HHSN268201800010INHLBI NIH HHS HHSN268201800011CNHLBI NIH HHS HHSN268201800011INHLBI NIH HHS HHSN268201800012CNHLBI NIH HHS HHSN268201800012INHLBI NIH HHS HHSN268201800014CNHLBI NIH HHS HHSN268201800014INHLBI NIH HHS HHSN268201800015INIDDK NIH HHS K23 DK117041NIMHD NIH HHS HHSN268201800013I
6 · The paper itself

Abstract

Background: Higher levels of ideal cardiovascular health (ICH) are associated with lower levels of aldosterone and incidence of cardiovascular disease (CVD). However, the degree to which aldosterone mediates the association between ICH and CVD incidence has not been explored. Thus, we investigated the mediational role of aldosterone in the association of 5 components of ICH (cholesterol, body mass index (BMI), physical activity, diet and smoking) with incident CVD and the mediational role of blood pressure (BP) and glucose in the association of aldosterone with incident CVD in a cohort of African Americans (AA). Methods: The Jackson Heart Study is a prospective cohort of AAs adults with data on CVD outcomes. Aldosterone, ICH metrics and baseline characteristics were collected at exam 1 (2000-2004). ICH score was developed by summing 5 ICH metrics (smoking, dietary intake, physical activity, BMI, and total cholesterol) and grouped into two categories (0-2 and ≥3 metrics). Incident CVD was defined as stroke, coronary heart disease, or heart failure. Cox proportional hazard regression models were used to model the association of categorical ICH score with incident CVD. The R Package Results: Among 3,274 individuals (mean age: 54±12.4 years, 65% female), there were 368 cases of incident CVD over a median of 12.7 years. The risk of incident CVD was 46% lower (HR: 0.54; 95%CI 0.36, 0.80) in those with ≥3 ICH metrics at baseline compared to 0-2. Aldosterone mediated 5.4% ( Conclusion: Aldosterone partially mediates the association of ICH with incident CVD and both blood pressure and glucose partially mediate the association of aldosterone with incident CVD, emphasizing the potential importance of aldosterone and ICH in risk of CVD among AAs.

Indexed as

AldosteroneCardiovascular diseaseIdeal cardiovascular health

Identifiers

PMID37114212
PMCPMC10126856
OpenAlexW4362578267

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.